328 related articles for article (PubMed ID: 15989025)
21. Primary invasive versus progressive invasive transitional cell bladder cancer: multicentric study of overall survival rate.
Ferreira U; Matheus WE; Nardi Pedro R; Levi D'Ancona CA; Reis LO; Stopiglia RM; Denardi F; Rodrigues Netto N; de Cássio Zequi S; da Fonseca FP; Lopes A; Cardoso Guimarães G; de Carvalho Fernandes R; Cardenuto Perez MD
Urol Int; 2007; 79(3):200-3. PubMed ID: 17940350
[TBL] [Abstract][Full Text] [Related]
22. Results of bladder-conserving treatment, consisting of brachytherapy combined with limited surgery and external beam radiotherapy, for patients with solitary T1-T3 bladder tumors less than 5 cm in diameter.
Blank LE; Koedooder K; van Os R; van de Kar M; van der Veen JH; Koning CC
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):454-8. PubMed ID: 17560734
[TBL] [Abstract][Full Text] [Related]
23. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
24. Management of muscle-invasive bladder cancer in Victoria, 1990-1995.
Millar JL; Frydenberg M; Toner G; Syme R; Thursfield V; Giles GG;
ANZ J Surg; 2006 Mar; 76(3):113-9. PubMed ID: 16626343
[TBL] [Abstract][Full Text] [Related]
25. [Electrovaporization in the treatment of bladder cancer].
Lopatkin NA; Martov AG; Gushchin BL; Kudriavtsev IuV; Sysoev PA
Urol Nefrol (Mosk); 1998; (5):9-12. PubMed ID: 9820036
[TBL] [Abstract][Full Text] [Related]
26. [The clinical study of 23 cases in patients with bladder cancer over 85 years old].
Owada F; Fukuda H; Saito T; Negishi T; Yamada T; Kageyama Y; Tari K; Tsujii T; Onase J; Saito H
Hinyokika Kiyo; 1989 Jul; 35(7):1141-4. PubMed ID: 2801405
[TBL] [Abstract][Full Text] [Related]
27. [Clinical study of preoperative radiotherapy of bladder cancer].
Shimada H; Imanaka K; Hashimura T; Hirota S; Yonezawa K; Soezima T; Izumiyama K; Kono M; Goji K; Hamami M
Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1385-90. PubMed ID: 2212829
[TBL] [Abstract][Full Text] [Related]
28. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.
Granfors T; Tomic R; Ljungberg B
Scand J Urol Nephrol; 2009; 43(4):293-9. PubMed ID: 19363744
[TBL] [Abstract][Full Text] [Related]
29. Organ preservation in invasive bladder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment?
Pos F; Horenblas S; Dom P; Moonen L; Bartelink H
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):678-86. PubMed ID: 15708245
[TBL] [Abstract][Full Text] [Related]
30. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
[TBL] [Abstract][Full Text] [Related]
31. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
Hata M; Miyanaga N; Tokuuye K; Saida Y; Ohara K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Hattori K; Shimazui T; Akaza H; Akine Y
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1371-9. PubMed ID: 16580495
[TBL] [Abstract][Full Text] [Related]
32. [Results of organ-preserving therapy for invasive bladder cancer].
Matveev BP; Figurin KM; Toktomushev AT
Urologiia; 2002; (3):3-5. PubMed ID: 12180056
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of 300 patients with bladder cancer].
Mori Y; Arima M; Shimada K; Shima H; Ihara H; Yabumoto H; Hosokawa S; Taguchi K; Ikoma F
Hinyokika Kiyo; 1991 Oct; 37(10):1235-41. PubMed ID: 1755417
[TBL] [Abstract][Full Text] [Related]
34. [Surgical treatment for 217 patients with bladder transitional carcinoma].
Yu SL; Zhou FJ; Qin ZK; Han H; Liu ZW; Wang B; Wang H; Li YH
Ai Zheng; 2006 Jan; 25(1):73-5. PubMed ID: 16405754
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.
Chung PW; Bristow RG; Milosevic MF; Yi QL; Jewett MA; Warde PR; Catton CN; McLean M; Moore M; Tannock IF; Gospodarowicz MK
Urol Oncol; 2007; 25(4):303-9. PubMed ID: 17628296
[TBL] [Abstract][Full Text] [Related]
36. Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection.
Nielsen ME; Bastian PJ; Palapattu GS; Trock BJ; Schoenberg MP; Chan T; Rogers CG
Urology; 2007 Dec; 70(6):1091-5. PubMed ID: 18158024
[TBL] [Abstract][Full Text] [Related]
37. Radiochemotherapy after transurethral resection is an effective treatment method in T1G3 bladder cancer.
Akçetin Z; Todorov J; Tüzel E; Engehausen DG; Krause FS; Sauer R; Schrott KM; Rödel C
Anticancer Res; 2005; 25(3A):1623-8. PubMed ID: 16033071
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
39. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.
Novara G; De Marco V; Gottardo F; Dalpiaz O; Bouygues V; Galfano A; Martignoni G; Patard JJ; Artibani W; Ficarra V
Cancer; 2007 Oct; 110(8):1715-22. PubMed ID: 17724728
[TBL] [Abstract][Full Text] [Related]
40. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]